Earnings callsMarksans Pharma Limited
Every summarised call, newest first. Latest is Q1 FY27, held 13 Aug 2026.
- Q1 FY27Positive tone
The company started FY27 with record quarterly revenue, EBITDA, and PAT, driven by strong European growth via acquisitions and organic expansion across all geographies.